Page 47 - GPD-4-1
P. 47

Gene & Protein in Disease                                               GPER1 in brain and heart diseases



               doi: 10.1016/j.abb.2024.109882                     receptor signaling. Hypertension. 2006;47(6):1019-1026.
            25.  De Francesco EM, Pellegrino M, Santolla MF, et al. GPER      doi: 10.1161/01.HYP.0000223064.62762.0b
               mediates activation of HIF1α/VEGF signaling by estrogens.   36.  Gohar EY. G protein-coupled estrogen receptor 1 as a novel
               Cancer Res. 2014;74(15):4053-4064.
                                                                  regulator of blood pressure.  Am J Physiol Renal Physiol.
               doi: 10.1158/0008-5472.CAN-13-3590                 2020;319(4):F612-F617.
            26.  Prossnitz ER, Barton M. The G protein-coupled oestrogen      doi: 10.1152/ajprenal.00045.2020
               receptor GPER in health and disease: An update. Nat Rev   37.  Di Mattia RA, Mariángelo JIE, Blanco PG,  et al. The
               Endocrinol. 2023;19(7):407-424.
                                                                  activation of the G protein-coupled estrogen receptor
               doi: 10.1038/s41574-023-00822-7                    (GPER) prevents and regresses cardiac hypertrophy. Life Sci.
                                                                  2020;242:117211.
            27.  Weiser MJ, Foradori CD, Handa RJ. Estrogen receptor
               beta in the brain: From form to function.  Brain Res Rev.      doi: 10.1016/j.lfs.2019.117211
               2008;57(2):309-320.
                                                               38.  Deschamps AM, Murphy E. Activation of a novel estrogen
               doi: 10.1016/j.brainresrev.2007.05.013             receptor, GPER, is cardioprotective in male and female rats.
                                                                  Am J Physiol Heart Circ Physiol. 2009;297(5):H1806-H1813.
            28.  Lu Y, Jiang Q, Yu L, et al. 17β-estradiol rapidly attenuates
               P2X3 receptor-mediated peripheral pain signal transduction      doi: 10.1152/ajpheart.00283.2009
               via ERα and GPR30. Endocrinology. 2013;154(7):2421-2433.
                                                               39.  Machuki JO, Zhang HY, Geng J, et al. Estrogen regulation
               doi: 10.1210/en.2012-2119                          of cardiac cAMP-L-type Ca2+ channel pathway modulates
                                                                  sex differences in basal contraction and responses to β2AR-
            29.  Takanami K, Sakamoto H, Matsuda KI, et al. Expression of
               G protein-coupled receptor 30 in the spinal somatosensory   mediated stress in left ventricular apical myocytes.  Cell
               system. Brain Res. 2010;1310:17-28.                Commun Signal. 2019;17(1):34.
                                                                  doi: 10.1186/s12964-019-0346-2
               doi: 10.1016/j.brainres.2009.11.004
                                                               40.  Ogola BO, Zimmerman MA, Sure VN,  et al. G  protein-
            30.  Hazell GGJ, Yao ST, Roper JA, Prossnitz ER, O’Carroll AM,
               Lolait SJ. Localisation of GPR30, a novel G protein-coupled   coupled  estrogen  receptor  protects  from  angiotensin
               oestrogen receptor, suggests multiple functions in rodent brain   II-induced increases in pulse pressure and oxidative stress.
               and peripheral tissues. J Endocrinol. 2009;202(2):223-236.  Front Endocrinol (Lausanne). 2019;10:586.
                                                                  doi: 10.3389/fendo.2019.00586
               doi: 10.1677/JOE-09-0066
                                                               41.  Carregosa D, Mota S, Ferreira S, et al. Overview of beneficial
            31.  Kuhn J, Dina OA, Goswami C, Suckow V, Levine JD,
               Hucho   T. GPR30 estrogen receptor agonists  induce   effects  of  (Poly)phenol  metabolites  in  the  context  of
               mechanical hyperalgesia in the rat.  Eur J Neurosci.   neurodegenerative diseases on model organisms. Nutrients.
               2008;27(7):1700-1709.                              2021;13(9):2940.
                                                                  doi: 10.3390/nu13092940
               doi: 10.1111/j.1460-9568.2008.06131.x
                                                               42.   Brahmachari   G.   Discovery  and  Development  of
            32.  Brandt N, Rune GM. Sex-dependency of oestrogen-induced
               structural synaptic plasticity: Inhibition of aromatase   Neuroprotective Agents from Natural Products. Netherlands:
               versus application of estradiol in rodents.  Eur J Neurosci.   Elsevier; 2018.
               2020;52(1):2548-2559.                              doi: 10.1016/C2014-0-04884-8
               doi: 10.1111/ejn.14541                          43.  Goyal A, Verma A, Agrawal N. Dietary phytoestrogens:
                                                                  Neuroprotective role in Parkinson’s disease. Curr Neurovasc
            33.  Prossnitz ER, Barton M. The G-protein-coupled estrogen
               receptor GPER in health and disease. Nat Rev Endocrinol.   Res. 2021;18(2):254-267.
               2011;7(12):715-726.                                doi: 10.2174/1567202618666210604121233
               doi: 10.1038/nrendo.2011.122                    44.  Cosselman KE, Navas-Acien A, Kaufman JD. Environmental
                                                                  factors in cardiovascular disease. Nat Rev Cardiol.
            34.  Wang H, Sun X, Chou J,  et al. Cardiomyocyte-specific
               deletion of the G protein-coupled estrogen receptor (GPER)   2015;12(11):627-642.
               leads to left ventricular dysfunction and adverse remodeling:      doi: 10.1038/nrcardio.2015.152
               A sex-specific gene profiling analysis. Biochim Biophys Acta   45.  Żabińska M, Wiśniewska K, Węgrzyn G, Pierzynowska K.
               Mol Basis Dis. 2017;1863(8):1870-1882.
                                                                  Exploring the physiological role of the G protein-coupled
               doi: 10.1016/j.bbadis.2016.10.003                  estrogen receptor (GPER) and its associations with human
                                                                  diseases. Psychoneuroendocrinology. 2024;166:107070.
            35.  Meyer MR, Haas E, Barton M. Gender differences of
               cardiovascular disease: New perspectives for estrogen      doi: 10.1016/j.psyneuen.2024.107070


            Volume 4 Issue 1 (2025)                         18                              doi: 10.36922/gpd.4632
   42   43   44   45   46   47   48   49   50   51   52